# Gilead Sciences, Inc. (GILD) — Q4-2009 Earnings Results

**Report date:** 2010-01-26 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q4-2009

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Down N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.93 | N/A | +13.41% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook, emphasizing the strength of their product offerings. However, they recognized ongoing challenges in the market.

**Key quotes:**

> Management highlighted the strong performance in their key therapeutic areas.

> They expressed confidence in their pipeline but acknowledged market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Gilead Sciences reported a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the strong EPS could suggest resilience in their business despite market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q4-2009_